TGFB1 and neoplasm: By explicitly separating tumor-cell state from MSI status and stromal desmoplasia, IMF explains why F-high tumors, marked by cancer-associated fibroblast (CAF)/TGF-β-driven remodeling and immune exclusion, track with adverse outcomes and therapeutic resistance, nominating microenvironment-modulating strategies as rational combinations [5,10].